TASLY
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

TASLY Trademark

Serial Number: 79214474 • Registration: 5477867

TASLY is a trademark filed by Tasly Pharmaceutical Group Co., Ltd. on November 10, 2016. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Tasly Pharmaceutical Group Co., Ltd. (3 trademarks)

Tasly Modern TCM Garden,

Entity Type: 99

Trademark Details

Filing Date

November 10, 2016

Registration Date

May 29, 2018

Published for Opposition

March 13, 2018

Cancellation Date

December 13, 2024

Goods & Services

Medicine for human purposes for the secondary prevention of coronary heart disease (CHD) and the treatment of acute maintain sickness (AMS) , diabetic retinopathy, asthma, cancer, cardiovascular and cerebrovascular disease, coronary artery disease, angina pectoris, myocardial infarction, cough, depression, diabetes and its complications, enteritis, febris, headache, heart disease, hepatitis, hepatopathy, high blood pressure, hypertriglyceridemia, hypercholesteremia, combined hyperlipidemia, insomnia, fatty liver disease, respiratory tract infection, psychosis, rhinitis; Chemico-pharmaceutical preparations for the secondary prevention of coronary heart disease (CHD) and the treatment of acute maintain sickness (AMS) , diabetic retinopathy, asthma, cancer, cardiovascular and cerebrovascular disease, coronary artery disease, angina pectoris, myocardial infarction, cough, depression, diabetes and its complications, enteritis, febris, headache, heart disease, hepatitis, hepatopathy, high blood pressure, hypertriglyceridemia, hypercholesteremia, combined hyperlipidemia, insomnia, fatty liver disease, respiratory tract infection, psychosis, rhinitis; Raw material medicine for the secondary prevention of coronary heart disease (CHD) and the treatment of acute maintain sickness (AMS) , diabetic retinopathy, asthma, cancer, cardiovascular and cerebrovascular disease, coronary artery disease, angina pectoris, myocardial infarction, cough, depression, diabetes and its complications, enteritis, febris, headache, heart disease, hepatitis, hepatopathy, high blood pressure, hypertriglyceridemia, hypercholesteremia, combined hyperlipidemia, insomnia, fatty liver disease, respiratory tract infection, psychosis, rhinitis; Biomedicine for the secondary prevention of coronary heart disease (CHD) and the treatment of acute maintain sickness (AMS) , diabetic retinopathy, asthma, cancer, cardiovascular and cerebrovascular disease, coronary artery disease, angina pectoris, myocardial infarction, cough, depression, diabetes and its complications, enteritis, febris, headache, heart disease, hepatitis, hepatopathy, high blood pressure, hypertriglyceridemia, hypercholesteremia, combined hyperlipidemia, insomnia, fatty liver disease, respiratory tract infection, psychosis, rhinitis; pharmaceutical herbs for medical purposes; Prepared Chinese medicine for the secondary prevention of coronary heart disease (CHD) and the treatment of acute maintain sickness (AMS) , diabetic retinopathy, asthma, cancer, cardiovascular and cerebrovascular disease, coronary artery disease, angina pectoris, myocardial infarction, cough, depression, diabetes and its complications, enteritis, febris, headache, heart disease, hepatitis, hepatopathy, high blood pressure, hypertriglyceridemia, hypercholesteremia, combined hyperlipidemia, insomnia, fatty liver disease, respiratory tract infection, psychosis, rhinitis; Capsules for medicines, namely, capsules sold empty for pharmaceuticals; Pharmaceutical preparations for the secondary prevention of coronary heart disease (CHD) and the treatment of acute maintain sickness (AMS) , diabetic retinopathy, asthma, cancer, cardiovascular and cerebrovascular disease, coronary artery disease, angina pectoris, myocardial infarction, cough, depression, diabetes and its complications, enteritis, febris, headache, heart disease, hepatitis, hepatopathy, high blood pressure, hypertriglyceridemia, hypercholesteremia, combined hyperlipidemia, insomnia, fatty liver disease, respiratory tract infection, psychosis, rhinitis; Dietetic food and beverages adapted for medical use; bath preparations, medicated; Medical analgesic preparations; preparations for the treatment of burns; Syrups for pharmaceutical purposes for the secondary prevention of coronary heart disease (CHD) and the treatment of acute maintain sickness (AMS) , diabetic retinopathy, asthma, cancer, cardiovascular and cerebrovascular disease, coronary artery disease, angina pectoris, myocardial infarction, cough, depression, diabetes and its complications, enteritis, febris, headache, heart disease, hepatitis, hepatopathy, high blood pressure, hypertriglyceridemia, hypercholesteremia, combined hyperlipidemia, insomnia, fatty liver disease, respiratory tract infection, psychosis, rhinitis; vitamin preparations; sunburn preparations for pharmaceutical purposes; vaccines; detergents for medical purposes; disinfectants for hygiene purposes; digestives for pharmaceutical purposes; mineral water for medical purposes; Mineral salts for medical purposes; purgatives; meal for pharmaceutical purposes; flour for pharmaceutical purposes; febrifuges; medicinal tea; pharmaceutical preparations for the treatment of cranial or facial nerve disorders; anthelmintics; Pharmaceutical Gelatin, namely, gelatin capsules sold empty for pharmaceuticals ; germicides; greases for medical purposes; chemical preparations for the diagnosis of pregnancy; medicinal oils; medicinal herbs; Lotions for pharmaceutical purposes, namely, anti-bacteria hand washing solution, oral washings, gynecological washings, anorectal washings; Ointments for pharmaceutical purposes, namely, sunburn ointments, anti-inflammatory ointments, hemorrhoidal ointments, frostbite salve for pharmaceutical purposes, eye ointments; Pectin for pharmaceutical purposes for the secondary prevention of coronary heart disease (CHD) and the treatment of acute maintain sickness (AMS) , diabetic retinopathy, asthma, cancer, cardiovascular and cerebrovascular disease, coronary artery disease, angina pectoris, myocardial infarction, cough, depression, diabetes and its complications, enteritis, febris, headache, heart disease, hepatitis, hepatopathy, high blood pressure, hypertriglyceridemia, hypercholesteremia, combined hyperlipidemia, insomnia, fatty liver disease, respiratory tract infection, psychosis, rhinitis; herbs teas for medicinal purposes; pharmaceutical preparations for skin care; pharmaceutical preparations for treating dandruff; first-aid boxes, filled; medicinal roots; medicinal herbal preparations, namely, tonics medicine; sedatives; soporifics; sugar for medical purposes; Biological preparations for medical purposes for the secondary prevention of coronary heart disease (CHD) and the treatment of acute maintain sickness (AMS) , diabetic retinopathy, asthma, cancer, cardiovascular and cerebrovascular disease, coronary artery disease, angina pectoris, myocardial infarction, cough, depression, diabetes and its complications, enteritis, febris, headache, heart disease, hepatitis, hepatopathy, high blood pressure, hypertriglyceridemia, hypercholesteremia, combined hyperlipidemia, insomnia, fatty liver disease, respiratory tract infection, psychosis, rhinitis; medical preparations for slimming purposes; by-products of the processing of cereals for dietetic or medical purposes; medicines for dental purposes; Diagnostic preparations for medical purposes for the secondary prevention of coronary heart disease (CHD) and the treatment of acute maintain sickness (AMS) , diabetic retinopathy, asthma, cancer, cardiovascular and cerebrovascular disease, coronary artery disease, angina pectoris, myocardial infarction, cough, depression, diabetes and its complications, enteritis, febris, headache, heart disease, hepatitis, hepatopathy, high blood pressure, hypertriglyceridemia, hypercholesteremia, combined hyperlipidemia, insomnia, fatty liver disease, respiratory tract infection, psychosis, rhinitis; medicinal drinks; ferments for pharmaceutical purposes; chemical reagents for medical or veterinary purposes; Dietary fiber to aid digestion; enzyme preparations for medical purposes; amino acids for pharmaceutical purposes; mouthwashes for medical purposes; appetite suppressants for medical purposes; adjuvants for medical purposes; Weight-reducing aid, namely, weight management supplements; Medicine for the treatment of sunburns; Food supplements, namely, antioxidants used for medicinal purposes; acne treatment preparation; Medicinal herbal preparations, namely, lysine electuary; oral rehydration salts; Medicinal liquor for the secondary prevention of coronary heart disease (CHD) and the treatment of acute maintain sickness (AMS) , diabetic retinopathy, asthma, cancer, cardiovascular and cerebrovascular disease, coronary artery disease, angina pectoris, myocardial infarction, cough, depression, diabetes and its complications, enteritis, febris, headache, heart disease, hepatitis, hepatopathy, high blood pressure, hypertriglyceridemia, hypercholesteremia, combined hyperlipidemia, insomnia, fatty liver disease, respiratory tract infection, psychosis, rhinitis; Medicinal herbal preparations, namely, ginseng electuary; Ginseng for medicinal use; Medicinal herbal preparations, namely, medlar; Dietetic beverages adapted for medicinal purposes, namely, weight-reducing tea; dietetic foods adapted for medical purposes; dietetic beverages adapted for medical purposes; nutritional food additives for medical purposes in the nature of natural food extracts derived from fish, meat, vegetables, fruits; food for babies; milk powder for infants; air purifying preparations; Medicated animal washes; Veterinary preparations for the secondary prevention of coronary heart disease (CHD) and the treatment of acute maintain sickness (AMS) , diabetic retinopathy, asthma, cancer, cardiovascular and cerebrovascular disease, coronary artery disease, angina pectoris, myocardial infarction, cough, depression, diabetes and its complications, enteritis, febris, headache, heart disease, hepatitis, hepatopathy, high blood pressure, hypertriglyceridemia, hypercholesteremia, combined hyperlipidemia, insomnia, fatty liver disease, respiratory tract infection, psychosis, rhinitis; Medicated animal feed; biocides; vermin destroying preparations; sanitary towels; wadding for medical purposes; medical dressings; rubber for dental purposes; teeth filling material; diaper for pets

Filing History

TOTAL INVALIDATION PROCESSED BY THE IB
Feb 19, 2026 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Feb 1, 2026 INTS
INVALIDATION PROCESSED
Feb 1, 2026 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Aug 13, 2025 INTR
CANCELLED SECTION 71
Dec 13, 2024 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
May 29, 2023 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Sep 29, 2018 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Sep 11, 2018 FICS
FINAL DISPOSITION PROCESSED
Sep 11, 2018 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Aug 29, 2018 FICR
REGISTERED-PRINCIPAL REGISTER
May 29, 2018 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 13, 2018 NPUB
PUBLISHED FOR OPPOSITION
Mar 13, 2018 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 21, 2018 NONP
REFUSAL PROCESSED BY IB
Feb 10, 2018 RFNT
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 1, 2018 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 13, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 12, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 12, 2018 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 21, 2017 GNRN
NON-FINAL ACTION E-MAILED
Dec 21, 2017 GNRT
NON-FINAL ACTION WRITTEN
Dec 21, 2017 CNRT
ASSIGNED TO EXAMINER
Dec 7, 2017 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 21, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 20, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 20, 2017 TROA
REFUSAL PROCESSED BY IB
Sep 22, 2017 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 1, 2017 RFCS
REFUSAL PROCESSED BY MPU
Sep 1, 2017 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 30, 2017 RFCR
NON-FINAL ACTION WRITTEN
Aug 29, 2017 CNRT
APPLICATION FILING RECEIPT MAILED
Aug 25, 2017 MAFR
ASSIGNED TO EXAMINER
Aug 21, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 21, 2017 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 17, 2017 REPR